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Abstract
Introduction. Cardiovascular diseases are the main cause of death worldwide. In the last 40 years we can observe an 
increase in prevalence of CVDs among young population [1]. Control of risk factors is especially important in young 
group of patients because the long-term prognosis for this group is particularly unfavorable [2].
Materials and methods. Medical records of the one hundred consecutive patients hospitalized between 2014–2017 in 
the Department of Cardiac and Vascular Diseases in Cracow Specialist Hospital were analyzed, with special emphasis 
put on the presence of the myocardial infarction risk factors. The study included 58 women under the age of 55 and 42 
men younger than 45 years old, who were divided into two groups: with or without history of acute coronary syndrome.
Results.	The studied population consisted of 58% of females, median age of all subjects was 45.5 years (42.75; 
53; Q1; Q3 respectively). 86% were characterized by the increased LDL concentrations higher than 1.8 mmol/l, 
65% have smoked cigarettes and 86.4% had thickened intima-media complex. HDL level was below the norm in 
47.4% of the group with ACS and only in 20.9% of the group without ACS (P = 0.006). Additionally, significant 
differences between the groups in combined risk factors were observed, i.e.: decreased HDL level accompanied by 
increased LDL (40.4% with ACS, 20.9% without ACS; P = 0.04), past and current cigarettes smoking (38.6% with 
ACS, 18.6% without ACS; P = 0.03) or arterial hypertension (40.4% with ACS, 18.6% without ACS; P = 0.02).
Conclusion. The most important risk factor of acute myocardial infarction in the studied group with early onset of 
CVD was reduced HDL level.
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Streszczenie
Wstęp.	Choroby sercowo-naczyniowe są główną przyczyną zgonów na świecie. W ostatnich 40 latach obserwuje się 
wzrost występowania ChSN w młodej populacji [1]. Kontrola czynników ryzyka jest szczególnie istotna u młodszych 
pacjentów, ponieważ długoterminowe prognozy dla tej grupy są szczególnie niekorzystne [2].
Materiały i metody. Przeanalizowano historie chorób 100 kolejnych pacjentów hospitalizowanych w Klinice 
Chorób Serca i Naczyń w Szpitalu im. Jana Pawła II w Krakowie (2014–2017), ze szczególnym uwzględnieniem 
czynników ryzyka chorób sercowo-naczyniowych. Do badania włączono 58 kobiet poniżej 45. roku życia oraz  
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42 mężczyzn poniżej 55. roku życia. Pacjentów podzielono na dwie grupy według kryterium przebytego ostrego 
zespołu wieńcowego (OZW) w przeszłości.
Wyniki.	Kobiety stanowiły 58% badanej populacji, mediana wieku wszystkich badanych wynosiła 45,5 roku (42,75; 
53; odpowiednio Q1; Q3). U 86% pacjentów z badanej populacji stwierdzono stężenie cholesterolu frakcji LDL 
powyżej 1,8 mmol/l, 65% paliło papierosy, a u 86,4% stwierdzono pogrubiony kompleks intima–media. Stężenia 
cholesterolu frakcji HDL poniżej normy odnotowano u 47,4% osób w grupie z historią OZW i tylko u 20,9%  
w grupie bez OZW (p = 0,006). W występowaniu kombinacji czynników ryzyka istotne różnice między grupami 
zaobserwowano przy obniżonym stężeniu cholesterolu frakcji HDL, któremu towarzyszyło podniesione stężenie 
LDL (40,4% z OZW, 20,9% bez OZW; p = 0,04), palenie papierosów (38,6% z OZW, 18,6% bez OZW; p = 0,03) 
lub nadciśnienie tętnicze (40,4% z OZW, 18,6% bez OZW; p = 0,02).
Wnioski.	Najważniejszym czynnikiem ryzyka ostrego zespołu wieńcowego w badanej populacji było obniżone 
stężenie cholesterolu HDL.
Słowa kluczowe: czynniki ryzyka, przedwczesna choroba wieńcowa, ostry zespół wieńcowy
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Introduction
Cardiovascular diseases (CVDs) are disorders of 
the heart and blood vessels that include coronary 
heart disease, cerebrovascular disease, rheumatic 
heart disease and other conditions. Four out of five 
CVD deaths are due to heart attacks and strokes [3]. 
CVDs are the most common causes of death among 
European population, despite available novel diag-
nostic tools and treatment modalities. In 2015 ap-
proximately 17.7 million people died of CVDs, in 
comparison to 8.9 million deaths caused by cancer, 
worldwide [4]. Although the deaths related to CVDs 
occur the most frequently in older patients (61% in 
the 70+ age group [5]), the ischaemic heart disease 
is also a leading cause of death in Europe in younger 
populations (above 30 years old) [4].
In Poland in the years between 1960 and 1991 
there was a notable increase in deaths caused by 
CVDs — from 23.4% to 52.7% of all deaths. This 
is evident even despite recent decrease in CVD-re-
lated mortality to 45.1% (in 2014) and it is still 
much higher than an average for the EU (38.1%). 
These numbers may be caused by poor control of 
the cardiovascular risk factors in Polish society: more 
than half of population has excess weight and lacks 
physical activity, 77% of adults are diagnosed with 
dyslipidemia, out of which only 6% is treated, and 
30% of men and 20% of woman smoke. All in all, 
more than 90% of men and 89% of women have 
at least one CVD risk factor [6]. This may partially 
be a consequence of an inadequate awareness of the 
cardiovascular risk factors during early life, as shown 
among high-school adolescents [7].
In effort to reduce the impact of CVD on our so-
cieties, more effective preventive measures need to be 
implemented, as the vast majority of the CVDs may 
be avoided by modifiable risk factors control [8], 
such as obesity, smoking, excessive alcohol use and 
efficient treatment of the comorbidities such as arte-
rial hypertension or diabetes mellitus [9].
The management of the modifiable CVD-risk 
factors constitutes routine clinical practice in mid-
dle-aged and elder patients, but they are also import-
ant in young adults. Even though less than 10% of all 
patients with MI are below the age of 45, autopsies 
show that approximately 50% of young individuals 
have evidently obliterated coronary arteries [10]. In 
this study we aimed to examine prevalence of CVD 
risk factors in population of patients with diagnosis 
of premature cardiovascular disease, with and with-
out history of ACS, as the long-term prognosis for 
these patients is not favourable [2]. We also sought 
to investigate the differences in prevalent CVD-risk 
factors between the defined groups.
Material and methods
One hundred consecutive medical records of patients 
hospitalized between 2014 and 2017 in the Department 
of Cardiac and Vascular Diseases in John Paul II Clin-
ical Hospital in Cracow were analyzed. We specifically 
focused on the myocardial infarction risk factors. The in-
clusion criteria were: 1. cardiovascular disease confirmed 
by angiography and 2. the age limit at 55 of years for 
women and 45 years for men. All patients were char-
acterized by very high 10-years risk of fatal myocardial 
infarction assessed with the ESC 2016 guidelines [7].
Twelve risk factors were analyzed: increased 
low-density lipoprotein (LDL) serum concentra-
tions, decreased high-density lipoprotein (HDL) 
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serum concentration, triglycerides (TG) level over 
the norm, total cholesterol ratio over the norm, 
high-sensitivity CRP (hsCRP) over the norm, arter-
ial hypertension (AH), diabetes mellitus (DM), inti-
ma-media thickness (IMT), body mass index (BMI), 
myocardial infarction (MI) history, smoking history, 
family history.
While examining the aforementioned factors fol-
lowing cut-off values for patients with very high 
risk of fatal myocardial infarction in next ten years 
were assumed: 4.9 mmol/L for total cholesterol ratio, 
1.8 mmol/L for LDL, 1.7 mmol/L for TG, for HDL: 
1 mmol/L for men and 1.3 mmol/L for women, 
3.1 mg/L for CRP, 60 ml/min/1.73 m2 for eGFR.
Means and standard deviations were calculated for 
the following risk factors in studied population: LDL 
level, total cholesterol, BMI. Median and quartiles were 
calculated for: HDL, TG and hsCRP concentrations.
The comparative analysis was performed between 
the two subgroups of patients i.e.: with, and without 
the history of the acute coronary syndrome (ACS). 
The group with the history of ACS consisted of 30 
women with median of age 51.5 (49; 53.75; Q1; 
Q3 respectively), and 27 men with median of age 42 
(40.5; 43). The subgroup without the history of ACS 
consisted of 28 women with median of age 53 (52; 
54) and 15 men aged 42 (40; 44) years old.
Statistical analysis
All statistical analyses were performed with Statistica 
v.13, StatSoft, PL. Data are presented as means ± 
SD, medians (Q1; Q3) or number and percentage 
(n, [%]). Differences in the occurrence of the risk 
factors, and prevalent comorbidities in both groups 
were calculated using chi-square test. t-Student test, 
and Mann-Withney test were used for quantitative 
variables, where appropriate.
Missing data were substituted with the popula-
tion means (three patients with no lipid profile). 
Seven of the patients missed data for hsCRP, eight 
for BMI, nineteen for IMC and thirty for family 
history, so data concerning these variables were ana-
lyzed accordingly for total patients of 93, 92, 81 and 
70. To avoid major bias we decided not to include 
these variables in analysis of combined risk factors. 
P-value of less than 0.05 was considered valid for all 
calculations.
Results
Basic demographic and clinical data of patients are 
summarized in Table IA and IB. All of examined 
patients had two or more of examined risk factors/ 
/subclinical damage, with the median of six (Table IA). 
The most common ones in all studied population 
were LDL level above the norm (86%), and thick-
ened intima-media complex (86.2%). 71% had es-
tablished AH, 57% with history of smoking and 
76.1% had BMI over 25 kg/m2. Less common risk 
factors were: an increased CRP levels, low HDL, 
increased total cholesterol, TGs over the norm, 
Table IA. Clinical characteristic of analyzed patients
Factors All patients With MI Without MI P-value
Number Percent Number Percent Number Percent
Males 42 42% 27 47.37% 25 34.88% 0.21
Females 58 58% 30 52.63% 28 65.12% 0.21
LDL > N 86 86% 49 85.96% 37 86.05% 0.99
HDL < N 36 36% 27 47.37% 9 20.93% 0.006
TG > N 25 25% 16 28.07% 9 20.93% 0.41
TC > N 33 33% 18 31.58% 15 34.88% 0.73
hsCRP > N * 43 46.24% 28 53.85% 15 36.59% 0.10
AH 71 71% 42 73.68% 29 67.44% 0.50
DM 24 24% 14 24.56% 12 27.91% 0.71
IMC > N ** 70 86.42% 40 85.11% 30 88.24% 0.68
BMI ≥ 25 *** 70 76.09% 39 78% 31 72.09% 0.64
Positive FH of MI**** 34 48.57% 12 35.29% 22 61.11% 0.03
Smoking 65 67.71% 41 71.93% 24 55.81% 0.28
N — norm; MI — myocardial infarction; AH — arterial hypertention; DM — diabetes mellitus; HDL — high-density lipoprotein; LDL — low-density lipoprotein; IMC — intima media complex; hsCRP — high sensitivity 
C-reactive protein; FH — family history; BMI — body mass index; TG — triglicerydes, TC — total cholesterol
*percentages counted for patients with complete data (total: 93, with MI: 52, without MI: 41); **percentages counted for patients with complete data (total: 81, with MI: 47, without MI: 34); ***percentages counted 
for patients with complete data (total: 92, with MI: 50, without MI: 42); ****percentages counted for patients with complete data (total: 70, with MI: 34, without MI: 36)
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Table IB. Clinical characteristics of patients with and without MI
Factors All patients With MI Without MI P-value
Mean ± Sd
*median (q1;q3)
Mean ± Sd
*median (q1;q3)
Mean ± Sd
*median (q1;q3)
Age (years) 45.5 (42.75; 53)* 44 (42; 52)* 51 (43; 53)* 0.08
BMI [kg/m2] 28.5 ± 5.1 29.1 ± 5.0 27.8 ± 5.0 0.23
LDL [mmol/L] 2.9 ± 1.0 2.9 ± 1.1 2.9 ± 1.0 0.99
HDL [mmol/L] 1.6 (1.01; 1.24)* 1.14 (0.88; 1.37)* 1.45 (1.19; 1.72)* 0.0003
TG [mmol/L] 1.28 (0.96; 3.52)* 1.28 (0.99; 1.78)* 1.28 (0.90; 1.61)* 0.32
TC [mmol/L] 4.6 ± 1.1 4.5 ± 1.1 4.7 ± 1.0 0.31
hsCRP [mg/L] 2.16 (1; 6.62)* 4 (1.18; 6.94)* 1.73 (0.89; 5.32)* 0.08
Table II. Risk factors in patients with MI and without MI
Risk factors All patients With MI Without MI P-value
Number Percent Number Percent Number Percent
HDL < N + LDL > N 32 32% 23 40.35% 9 20.93% 0.04
HDL < N + smoking 30 30% 22 38.60% 8 18.60% 0.03
HDL < N + AH 31 31% 23 40.35% 8 18.60% 0.02
HDL < N + DM 9 9% 7 12.28% 2 4.65% 0.19
LDL > N + smoking 57 57% 35 61.40% 22 51.16% 0.31
LDL > N + AH 58 58% 34 59.65% 24 55.81% 0.70
LDL > N + DM 20 20% 11 19.30% 9 20.93% 0.84
AH + smoking 47 47% 31 54.39% 16 37.21% 0.09
AH + DM 22 22% 12 21.05% 10 23.26% 0.79
DM + smoking 17 17% 12 21.05% 5 11.63% 0.21
decreased eGFR, presence of diabetes mellitus and 
positive family history of CVDs.
Differences between groups were observed in the 
decreased HDL level, as it was below the norm in 
47.4% of population with ACS in history and only 
in 20.9% of patients without ACS. Positive family 
history concerning CVDs was noted in the records 
of 35.3% of patients with ACS in history and 61.1% 
of individuals without cardiac incident in the past 
(Table IA).
In the analysis of the combined risk factors the 
significant differences were seen in three instances: 
the coexistence of low HDL blood levels and an in-
creased LDL levels, tobacco use or arterial hyperten-
sion. Prevalence of all three of them was similar and 
hovered around 40% of patients with ACS and 17% 
of patients without it, as seen in Table II.
Other than CV (cardiovascular), comorbidities 
were comparable between the groups. In the ACS- 
-group eight patients had a neoplasm in their medi-
cal history, three of them being mammary cancer, in 
comparison to two cases of cancer in group without 
ACS. This data did not show significant difference 
between groups, much like other analyzed conditions 
(Table III).
discussion
This study was focused on the analysis of CV risk 
factors among relatively young middle-aged patients 
with diagnosed coronary artery disease. In most cas-
es, the prevalence of observed risk factors in groups 
was comparable to the distribution in general pop-
ulation [11]. However, the findings underscore the 
importance of HDL as a protective factor against 
ACS, as its low blood-level was observed more fre-
quently in population with myocardial infarction 
in history. This trend repeats in the analysis of com-
bined risk factors, as the only ones differentiating 
both groups included HDL blood levels. These re-
sults align with few previous observational studies, 
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Table III. Comorbidities occurence in studied patients
Comorbidity All patients With MI Without MI P value
Number Percent Number Percent Number Percent
Arrhythmia 12 12% 5 8.8% 7 16.3% 0.25
Heart valve disease 17 17% 8 14.0% 9 20.9% 0.36
Arterial hypertension 71 71% 42 73.7% 29 67.4% 0.50
Diabetes mellitus 24 24% 14 24.6% 12 21.1% 0.71
Endocrine disorders other than DM 15 15% 8 14.0% 7 16.3% 0.76
Tumor 10 10% 8 14.0% 2 4.7% 0.12
Mental disorders 6 6% 3 5.3% 3 7.0% 0.72
like Framingham Study [12], where the major po-
tential lipid risk factor of coronary heart disease was 
low HDL cholesterol.
Surprisingly, we observed that patients who never 
experienced ACS had more commonly positive fami-
ly histories as compared to patients after ACS. One 
of the possibilities which could help to explain this 
difference is patients broader knowledge concerning 
such incidents and the awareness of the fact that they 
were at increased CVD risk. The other reason may 
be poorly taken history from patients with ACS, as 
enquiring about family history loses its importance 
in the light of underwent ACS or while managing 
fresh MI. Also the small number of patients (under-
powered study) may limit this finding.
Another factor we noticed was the incidence of 
cancer in patients’ history. While the numbers in 
both groups did not show statistical significance, 
we found it interesting that cancer morbidity was 
much higher, especially in group with ACS, than in 
general population of Poland [13]. This may be due 
to the usage of radiotherapy in the thoracic area to 
treat these conditions, which may increase the risk 
of CVD.
Due to the nature of analyzed material (medical 
records), incomplete data proved to be an obstacle in 
our work. Because of the lack of sufficient number 
of data concerning waist circumference (48 out of 
100 patients), we could not include this factor in 
analysis. Information about behavioral risk factors, 
such as physical activity, diet or stress levels was rare-
ly included in medical records. Patients’ history of 
substance abuse was often incomplete, for example in 
specifying number of cigarettes smoked a day. It may 
be a necessary to carry out further studies concerning 
aforementioned risk factors or consider employing 
specified questionnaires in assessing them, as they 
are easily modifiable and can be a crucial part of MI 
prevention. As some measurements and tests were 
not conducted in all cases, probably due to the lack 
of indications (IMT measurements) or conditions 
(BMI in immobilised patients) it should be taken 
under consideration while analyzing the results.
We found that many of existing studies concern 
CVD risk factors in elder population, less attention 
is paid to younger patients. We think it is important 
to determine main problems of this group, so that 
assessing and managing their condition becomes eas-
ier. It may be worth to consider whether the tools 
commonly used to calculate the cardiac risk are ap-
propriate for younger population.
Conclusion
All of the patients in the study had very high risk of 
MI in next ten years and in addition to treatment of 
their existing morbidities special attention should 
be paid to managing their risk factors of cardiac 
incidents. It should be achieved not only pharma-
cologically, but also by advocating for a change in 
a lifestyle, for example increasing physical activity or 
quitting smoking. These changes may help to reduce 
chance of MI in the future for example by increasing 
HDL-cholesterol level [14–16], as we found that 
although the most common CVD risk factor among 
studied population was elevated LDL-cholesterol lev-
el, it is HDL-cholesterol that may play crucial role in 
assessing the risk of ACS.
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